Clinical trial
Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
NCT02961634 is registered in ClinicalTrials.gov with MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
- Lead sponsor
- MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2017
- Completion date
- August 31, 2017
- Enrollment
- 46 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.